Price Alert

Radiopharm Theranostics L... (RADX)

NASDAQ: RADX · Real-Time Price · USD

7.11

0.91 (14.68%)

At close: Oct 06, 2025, 3:11 PM

Radiopharm Theranostics Cash Flow Statement

Financials in AUD. Fiscal year is July - June.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023
Net Income	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a	n/a	n/a
Other Non-Cash Items	-33.46M	-26.62M	-13.15M	-6.11M	-1.91M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	n/a
Operating Cash Flow	-33.46M	-26.62M	-13.15M	-6.11M	-1.91M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	3M	3M	n/a	n/a	n/a
Investing Cash Flow	3M	3M	n/a	n/a	n/a
Debt Repayment	2.2M	2.2M	2.2M	2.2M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-11.07M	-9.06M	-1.97M	-300K	-134K
Financial Cash Flow	64.58M	68.7M	29.95M	7.16M	1.98M
Net Cash Flow	34.54M	44.6M	16.74M	1.1M	60K
Free Cash Flow	-33.46M	-26.62M	-13.15M	-6.11M	-1.91M